Paulson & Co. - VALEANT PHARMACEUTICALS INTL ownership

VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 1 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2023. The put-call ratio across all filers is - and the average weighting 2.4%.

Quarter-by-quarter ownership
Paulson & Co. ownership history of VALEANT PHARMACEUTICALS INTL
ValueSharesWeighting
Q2 2018$484,299,000
+46.0%
20,839,0350.0%9.89%
+36.4%
Q1 2018$331,757,000
-23.4%
20,839,0350.0%7.25%
-14.2%
Q4 2017$433,035,000
+45.0%
20,839,0350.0%8.45%
+57.7%
Q3 2017$298,623,000
-20.9%
20,839,035
-4.5%
5.36%
+5.1%
Q2 2017$377,372,000
+76.5%
21,813,400
+12.5%
5.10%
+79.8%
Q1 2017$213,811,000
-24.0%
19,384,5000.0%2.84%
-20.0%
Q4 2016$281,463,000
-39.2%
19,384,500
+2.7%
3.55%
-29.4%
Q3 2016$463,283,000
+20.6%
18,871,000
-1.1%
5.02%
+28.6%
Q2 2016$384,110,000
+8.0%
19,072,000
+41.0%
3.90%
+48.5%
Q1 2016$355,779,000
-73.6%
13,527,700
+2.0%
2.63%
-67.4%
Q4 2015$1,348,479,000
-15.0%
13,265,900
+49.2%
8.06%
-2.1%
Q3 2015$1,585,798,000
-20.7%
8,890,000
-1.2%
8.23%
-10.7%
Q2 2015$1,999,350,000
+391.0%
9,000,000
+339.0%
9.22%
+344.8%
Q1 2015$407,171,000
+446.4%
2,050,000
+293.7%
2.07%
+438.4%
Q4 2014$74,517,000
+9.1%
520,7000.0%0.38%
+35.6%
Q3 2014$68,316,000
+8.3%
520,700
+4.1%
0.28%
+4.0%
Q2 2014$63,098,000
-52.1%
500,300
-50.0%
0.27%
-57.7%
Q1 2014$131,830,0001,000,0000.64%
Other shareholders
VALEANT PHARMACEUTICALS INTL shareholders Q3 2023
NameSharesValueWeighting ↓
Bruce & Co., Inc. 850,000$6,987,0002.38%
View complete list of VALEANT PHARMACEUTICALS INTL shareholders